Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Editorial Free access | 10.1172/JCI20394

Responsible conduct in animal research

Ushma Savla

Ph.D., Executive Editor

Find articles by Savla, U. in: PubMed | Google Scholar

Published November 15, 2003 - More info

Published in Volume 112, Issue 10 on November 15, 2003
J Clin Invest. 2003;112(10):1456–1456. https://doi.org/10.1172/JCI20394.
© 2003 The American Society for Clinical Investigation
Published November 15, 2003 - Version history
View PDF
Abstract

Laboratory animals play a crucial role in biomedical research – indeed many advances now incorporated into human health care would have been impossible without them. Informed and well-trained scientists have the privilege, but not the automatic right, to use animals as experimental subjects. This privilege must not be abused.

In the current issue of the JCI, we are issuing a retraction of a paper on the role of inducible costimulator (ICOS) in rheumatoid arthritis first published in March 2003. The article shows that in the absence of ICOS, mice normally susceptible to collagen-induced arthritis were completely protected from the disease. These results identified ICOS as a potential target for therapeutic intervention in rheumatoid arthritis.

While the paper was well received during peer review and may still contain legitimate ideas and findings relevant for the treatment of arthritis, the Editors of the JCI became aware soon after publication that there was a problem. As part of the manuscript submission process, we require authors whose work contains data procured from animal or human subjects to explicitly declare that the research was undertaken under the auspices of a protocol approved by an institutional review board (IRB) or institutional animal care and usage committee (IACUC). In this case, a declaration of this nature was made in the submitted and published manuscript, but it was not entirely accurate.

For both ethical and scientific reasons, all individuals whose hypotheses require validation through the use of laboratory animals must take the time to learn how to properly and ethically treat research subjects. Authors’ institutions must carefully review experimental protocols, and experiments should proceed only after approval has been granted. While trials may go awry or unintended reactions may occur during the course of experimentation, working closely with IACUCs is imperative. It is the responsibility of researchers and IACUCs to determine the best course of experimental procedures, especially when the chosen experiments cause animals to feel any distress. We must not take the responsibilities of animal care lightly.

As researchers ourselves, we understand that the scientific process can entail frustrations and disappointments. Experiments may fail for a number of reasons — technical complications or shortages of time, supplies, or students. But once a manuscript is published, the data held within can be freely used by other researchers to extend their own observations and, we hope, to affect treatment of human patients. For this reason, the onus is on the researcher to present a manuscript that can become part of the public record.

Our contribution to the scientific public record is built on a foundation of trust and integrity. The community has to be able to trust that the results we report from others are valid. Research journals play a vital role in the advancement of science through certification and dissemination of findings from authors to readers. In essence, journals place a stamp of credibility on data published within their pages, so it is essential that the findings reported therein are not only scientifically legitimate but also ethically sound.

The assumption that each author meets our scientific and ethical standards during the review process has allowed findings published in our journal to ultimately be translated to clinical therapies. But this trust will only endure if our authors are devoted to exemplifying the values associated with ethical scientific conduct. We have come to rely on our authors’ integrity as our readers rely on ours; we cannot police each author. In this case, we proceeded with peer review as the authors explicitly declared within their manuscript that their institution had approved the experiments presented.

We realize that IACUC policies and procedures can be complex, and it is our understanding that the authors are working closely with their IACUC to review the approval process in order to determine where the miscommunication occurred. However, the authors of the paper have agreed that at this time, under the policies of the JCI, which clearly state that all experiments must be formally approved by an IRB or IACUC, publication of the article cannot stand.

Version history
  • Version 1 (November 15, 2003): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Related comments

  • Responsible Conduct in Animal Research
    Arieh Bomzon

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts